Antisense Pharma Receives FDA Orphan Drug Designation for Trabedersen

News   Oct 05, 2012

 
Antisense Pharma Receives FDA Orphan Drug Designation for Trabedersen
 
 
 
FURTHER INFORMATION
 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 
 

Comments | 0 ADD COMMENT